Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Orbimed Advisors Llc

Affiliations

  • Large Shareholder, Director at Graybug Vision Inc. (GRAY), 2020-09-24
  • Large Shareholder, Director at Prelude Therapeutics Inc (PRLD), 2020-09-24
  • Large Shareholder, Director at Pmv Pharmaceuticals Inc. (PMVP), 2020-09-24
  • Large Shareholder, Director at 89Bio Inc. (ETNB), 2020-09-23
  • Large Shareholder, Director at Adicet Bio Inc. (ACET), 2020-09-18
  • Director at Inspire Medical Systems Inc. (INSP), 2020-08-19
  • Large Shareholder, Director at Acutus Medical Inc. (AFIB), 2020-08-13
  • Large Shareholder at Pandion Therapeutics Inc. (PAND), 2020-07-17
  • Director at Fusion Pharmaceuticals Inc. (FUSN), 2020-07-02
  • Director at Repare Therapeutics Inc. (RPTX), 2020-06-25
  • Large Shareholder, Director at Compass Therapeutics Inc. (NONE), 2020-06-24
  • Large Shareholder at Scpharmaceuticals Inc. (SCPH), 2020-05-26
  • Large Shareholder, Director at Xtant Medical Holdings Inc. (XTNT), 2020-05-20
  • Large Shareholder, Director at Oric Pharmaceuticals Inc. (ORIC), 2020-04-28
  • Large Shareholder at Alector Inc. (ALEC), 2020-04-17
  • Director at Keros Therapeutics Inc. (KROS), 2020-04-13
  • Large Shareholder, Director at Imara Inc. (IMRA), 2020-03-16
  • Large Shareholder at Cti Biopharma Corp (CTIC), 2020-03-10
  • Large Shareholder at Passage Bio Inc. (PASG), 2020-03-04
  • Large Shareholder, Director at Arcutis Biotherapeutics Inc. (ARQT), 2020-02-04
  • Large Shareholder, Director at Sierra Oncology Inc. (SRRA), 2020-01-31
  • Large Shareholder, Director at Tricida Inc. (TCDA), 2019-12-12
  • Large Shareholder at Tela Bio Inc. (TELA), 2019-11-14
  • Large Shareholder at Springworks Therapeutics Inc. (SWTX), 2019-09-19
  • Large Shareholder, Director at Corvus Pharmaceuticals Inc. (CRVS), 2019-08-08
  • Large Shareholder, Director at Prevail Therapeutics Inc. (PRVL), 2019-06-26
  • Large Shareholder at Principia Biopharma Inc. (PRNB), 2019-05-22
  • Large Shareholder, Director at Nextcure Inc. (NXTC), 2019-05-13
  • Director at Turning Point Therapeutics Inc. (TPTX), 2019-04-24
  • Large Shareholder at Avedro Inc (AVDR), 2019-02-20
  • Large Shareholder, Director at Alpine Immune Sciences Inc. (ALPN), 2019-01-23
  • Large Shareholder, Director at Synthorx Inc. (THOR), 2018-12-13
  • Large Shareholder, Director at Logicbio Therapeutics Inc. (LOGC), 2018-10-25
  • Director at Si-Bone Inc. (SIBN), 2018-10-19
  • Large Shareholder at Guardant Health Inc. (GH), 2018-10-11
  • Large Shareholder at Arvinas Holding Company Llc (ARVN), 2018-09-26
  • Large Shareholder at Steadymed Ltd. (STDY), 2018-09-07
  • Large Shareholder at Viewray Inc. (VRAY), 2018-08-21
  • Large Shareholder at Constellation Pharmaceuticals Inc (CNST), 2018-07-24
  • Large Shareholder at Crinetics Pharmaceuticals Inc. (CRNX), 2018-07-18
  • Large Shareholder, Director at Aerpio Pharmaceuticals Inc. (ARPO), 2018-07-02
  • Large Shareholder, Director at Armo Biosciences Inc. (ARMO), 2018-06-22
  • Director at Adaptimmune Therapeutics Plc (ADAP), 2018-06-06
  • Large Shareholder, Other at Rhythm Pharmaceuticals Inc. (RYTM), 2018-05-24
  • Large Shareholder, Other at Pieris Pharmaceuticals Inc. (PIRS), 2018-05-02
  • Large Shareholder at Audentes Therapeutics Inc. (BOLD), 2018-03-12
  • Director at Glaukos Corp (GKOS), 2018-03-07
  • Large Shareholder at Kala Pharmaceuticals Inc. (KALA), 2018-02-12
  • Director at Synlogic Inc. (SYBX), 2018-01-30
  • Director at Loxo Oncology Inc. (LOXO), 2017-12-12
  • Large Shareholder at Arsanis Inc. (ASNS), 2017-11-20
  • Large Shareholder at Roka Bioscience Inc. (ROKA), 2017-10-05
  • Large Shareholder at Aeglea Biotherapeutics Inc. (AGLE), 2017-02-21
  • Large Shareholder, Director at Nabriva Therapeutics Ag (NBRV), 2016-12-30
  • Large Shareholder, Director at Response Biomedical Corp (RBM), 2016-12-02
  • Large Shareholder at Relypsa Inc (RLYP), 2016-07-26
  • Large Shareholder, Director at Selecta Biosciences Inc (SELB), 2016-06-30
  • Director at Intellia Therapeutics Inc. (NTLA), 2016-05-13
  • Director at Otonomy Inc. (OTIC), 2015-11-30
  • Large Shareholder, Director at Dimension Therapeutics Inc. (DMTX), 2015-10-29
  • Large Shareholder at Sientra Inc. (SIEN), 2015-10-13
  • Director at Intercept Pharmaceuticals Inc (ICPT), 2015-07-22
  • Large Shareholder at Mirati Therapeutics Inc. (MRTX), 2015-02-05
  • Other at Acceleron Pharma Inc (XLRN), 2013-09-26
  • Large Shareholder at Ambit Biosciences Corp (AMBI), 2013-05-24
  • Large Shareholder at Supernus Pharmaceuticals Inc (SUPN), 2013-02-14
  • Director at Anthera Pharmaceuticals Inc (ANTH), 2013-02-02
  • Director at Amarin Corp Plc (AMRN), 2012-09-05
  • Large Shareholder at Complete Genomics Inc (GNOM), 2012-07-13
  • Large Shareholder at Pacira Pharmaceuticals Inc. (PCRX), 2012-03-13
  • Large Shareholder at Chemocentryx Inc. (CCXI), 2012-02-16
  • Large Shareholder at Athersys Inc / New (ATHX), 2011-04-30
  • Director at Nxstage Medical Inc. (NXTM), 2010-12-13
  • Large Shareholder at Kun Run Biotechnology Inc. (KURU.OB), 2010-05-10
  • Director at Biodel Inc (BIOD), 2009-06-11
  • Large Shareholder at Aryx Therapeutics Inc. (ARYX), 2009-05-26
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
AFIB $18.00 41,500 Large Shareholder, Director 41,500 2020-08-10 Filing
AFIB $18.00 373,500 Large Shareholder, Director 373,500 2020-08-10 Filing
FUSN $17.00 192,100 Director 192,100 2020-06-30 Filing
FUSN $17.00 705,900 Director 2,930,670 2020-06-30 Filing
RPTX $20.00 99,200 Director 99,200 2020-06-23 Filing
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
ETNB $28.00 137,500 Large Shareholder, Director 1,864,721 2020-09-21 Filing
ETNB $28.00 137,500 Large Shareholder, Director 1,864,721 2020-09-21 Filing
INSP $108.54 43,543 Director 0 2020-08-18 Filing
INSP $107.49 94,900 Director 43,543 2020-08-17 Filing
INSP $109.03 20,257 Director 138,443 2020-08-14 Filing